Docosahexaenoic acid protects human RPE cells against oxidative stress via PI3K/Akt m‐TOR/p70‐p85S6K pathways

Narjès Babchia(Centre National de la Recherche Scientifique), Lionel Brétillon(Université de Bourgogne), Laurent Leclère(NeuroDiderot), Lucy Martine(Université de Bourgogne), Stéphane Gregoire(Centre National de la Recherche Scientifique), António Araújo(Administração Regional de Saúde de Lisboa e Vale do Tejo), Bénédicte Buteau(Centre National de la Recherche Scientifique)
Acta Ophthalmologica
August 6, 2012
10.1111/j.1755-3768.2012.s055.x
Cited by 1

Related Papers

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2019|3.4k
FGFR a promising druggable target in cancer: Molecular biology and new drugs
|Critical Reviews in Oncology/Hematology|2017|203
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon
|Advances in experimental medicine and biology|2017|143
Lipid Composition of the Human Eye: Are Red Blood Cells a Good Mirror of Retinal and Optic Nerve Fatty Acids?
|PLoS ONE|2012|119
Cholesterol-24S-hydroxylase (CYP46A1) Is Specifically Expressed in Neurons of the Neural Retina
|Current Eye Research|2007|98